Add to ORKGof parietal cell autoantibodies and non-organ-specific autoantibodies on the treatment outcome of patients with hepatitis C virus infection: A pilot stud
BACKGROUND/AIMS: Recent studies in adult patients have established a relationship between hepatitis ...
AIM: To evaluate the overlap of autoimmune hepatitis in hepatitis C virus (HCV)-infected patients wi...
To evaluate the histological findings in patients with chronic hepatitis C and autoimmune features, ...
AIM: Various side effects have been reported in patients infected with hepatitis C virus (HCV) who w...
Background: Development of organ- and non-organ-specific autoantibodies has been reported in hepatit...
(See the editorial commentary by Bogdanos on pages 508–10) Background. Hepatitis C virus (HCV)–relat...
BACKGROUND: Hepatitis C virus (HCV)-related chronic hepatitis is frequently associated with non-orga...
Hepatotropic viruses, such as hepatitis B virus and hepatitis C virus (HCV), can take up permanent r...
none6The preliminary question regarding the clinical issue of the antiviral therapy in the HCV relat...
SUMMARY. Nonorgan-specific autoantibodies (NOSA) are common in patients with chronic hepatitis C vi...
Background: Autoantibody positivity is a common finding in chronic hepatitis C infection. The data a...
Chronic hepatitis C virus (HCV) infection and autoimmune disorders show a complex interplay, with HC...
Chronic hepatitis C virus (HCV) infection and autoimmune disorders show a complex interplay, with HC...
The mechanisms underlying the pathogenesis of autoimmune hepatitis are not fully understood, though ...
Abstract Background Chronic Hepatitis C Virus (HCV) infection has been commonly linked to the develo...
BACKGROUND/AIMS: Recent studies in adult patients have established a relationship between hepatitis ...
AIM: To evaluate the overlap of autoimmune hepatitis in hepatitis C virus (HCV)-infected patients wi...
To evaluate the histological findings in patients with chronic hepatitis C and autoimmune features, ...
AIM: Various side effects have been reported in patients infected with hepatitis C virus (HCV) who w...
Background: Development of organ- and non-organ-specific autoantibodies has been reported in hepatit...
(See the editorial commentary by Bogdanos on pages 508–10) Background. Hepatitis C virus (HCV)–relat...
BACKGROUND: Hepatitis C virus (HCV)-related chronic hepatitis is frequently associated with non-orga...
Hepatotropic viruses, such as hepatitis B virus and hepatitis C virus (HCV), can take up permanent r...
none6The preliminary question regarding the clinical issue of the antiviral therapy in the HCV relat...
SUMMARY. Nonorgan-specific autoantibodies (NOSA) are common in patients with chronic hepatitis C vi...
Background: Autoantibody positivity is a common finding in chronic hepatitis C infection. The data a...
Chronic hepatitis C virus (HCV) infection and autoimmune disorders show a complex interplay, with HC...
Chronic hepatitis C virus (HCV) infection and autoimmune disorders show a complex interplay, with HC...
The mechanisms underlying the pathogenesis of autoimmune hepatitis are not fully understood, though ...
Abstract Background Chronic Hepatitis C Virus (HCV) infection has been commonly linked to the develo...
BACKGROUND/AIMS: Recent studies in adult patients have established a relationship between hepatitis ...
AIM: To evaluate the overlap of autoimmune hepatitis in hepatitis C virus (HCV)-infected patients wi...
To evaluate the histological findings in patients with chronic hepatitis C and autoimmune features, ...